1 Nicolaides KH,Azar G,Byrne D,et al.Fetal nuchal translucency:ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ,1992,304:867-869. 2 Nicolaides KH,Sebire NJ,Snijders RJ.Down′s syndrome screening with nuchal translucency.Lancet,1997,349:438. 3 Salomon LJ,Alfirevic Z,Bilardo CM,et a1. ISUOG practice guidelines:performance of first-trimester fetal ultrasound scan.Ultrasound Obstet Gynecol,2013,41:102-113. 4 Souka AP,von Kaisenberg CS,Hyett JA,et a1. Increased nuchal translucency with normal karyotype.Am J Obstet Gynecol,2005,192:1005-1021. 5 Egloff M,Hervé B,Quibel T,et al.The diagnostic yield of chromosomal microarray analysis in fetuses with increased nuchal translucency:a French multicentre retrospective study.Ultrasound Obstet Gynecol,2018,52:715-721. 6 Pan M,Han J,Zhen L,et al.Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.Eur J Obstet Gynecol Reprod Biol,2016,197:164-167. 7 Grande M,Jansen FA,Blumenfeld YJ,et al.Genomic microarray in fetuses with increased nuchal translucency and normal karyotype:a systematic review and meta-analysis.Ultrasound Obstet Gynecol,2015,46:650-658. 8 Leung TY,Vogel I,Lau TK,et al.Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.Ultrasound Obstet Gynecol,2011,38:314-319. 9 Snijders RJ,Noble P,Sebire N,et al.UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.Lancet,1998,352:343-346. 10 Kearney HM,Thorland EC,Brown KK,et al.American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants.Genet Med,2011,13:680-685. 11 South ST,Lee C,LaMb AN,et al.ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis,including postnatal and prenatal applications:revision 2013. Genet Med,2013,15:901-909. 12 Souka AP,Snijders RJ,Novakov A,et a1. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.Ultrasound Obstet Gynecol,1998,11:391-400. 13 Maya I,Yacobson S,Kahana S,et a1.Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.Ultrasound Obstet Gynecol,2017,50:332-335. 14 杜柳,谢红宁,郑菊,等.颈部透明层增厚胎儿中CMA技术检测拷贝数变异的分析.中华妇产科杂志,2018,53:671-676. 15 ACOG.Practice bulletin No.163 summary:screening for fetal aneuploidy.Obstet Gynecol,2016,127:979-981. 16 Yang X,Li R,Fu F,et al.Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype.J Matern Fetal Neonatal Med,2017,30:194-198. 17 Huang LY,Pan M,Han J,et al.What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?.J Obstet Gynaecol,2018,38:498-501
